Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1267513.RAcBg3AL0jKVpq7Wba2KMvjhsgEGnku92CuONdDsTDmvI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1267513.RAcBg3AL0jKVpq7Wba2KMvjhsgEGnku92CuONdDsTDmvI130_assertion type Assertion NP1267513.RAcBg3AL0jKVpq7Wba2KMvjhsgEGnku92CuONdDsTDmvI130_head.
- NP1267513.RAcBg3AL0jKVpq7Wba2KMvjhsgEGnku92CuONdDsTDmvI130_assertion description "[Collectively, our study further elucidates the pathological effects of the G2019S mutation in the mammalian brain and supports the development of kinase inhibitors as a potential therapeutic approach for treating LRRK2-associated PD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267513.RAcBg3AL0jKVpq7Wba2KMvjhsgEGnku92CuONdDsTDmvI130_provenance.
- NP1267513.RAcBg3AL0jKVpq7Wba2KMvjhsgEGnku92CuONdDsTDmvI130_assertion evidence source_evidence_literature NP1267513.RAcBg3AL0jKVpq7Wba2KMvjhsgEGnku92CuONdDsTDmvI130_provenance.
- NP1267513.RAcBg3AL0jKVpq7Wba2KMvjhsgEGnku92CuONdDsTDmvI130_assertion SIO_000772 25731749 NP1267513.RAcBg3AL0jKVpq7Wba2KMvjhsgEGnku92CuONdDsTDmvI130_provenance.
- NP1267513.RAcBg3AL0jKVpq7Wba2KMvjhsgEGnku92CuONdDsTDmvI130_assertion wasDerivedFrom befree-2016 NP1267513.RAcBg3AL0jKVpq7Wba2KMvjhsgEGnku92CuONdDsTDmvI130_provenance.
- NP1267513.RAcBg3AL0jKVpq7Wba2KMvjhsgEGnku92CuONdDsTDmvI130_assertion wasGeneratedBy ECO_0000203 NP1267513.RAcBg3AL0jKVpq7Wba2KMvjhsgEGnku92CuONdDsTDmvI130_provenance.